Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Antonio Lopez-Beltran, Liang Cheng, Thomas Gevaert, Ana Blanca, Alessia Cimadamore, Matteo Santoni, Francesco Massari, Marina Scarpelli, Maria R. Raspollini & Rodolfo Montironi. (2020) Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers. Expert Review of Molecular Diagnostics 20:2, pages 231-243.
Read now
Read now
Qindong Liang, Guangjie Zhang, Wuxian Li, Jing Wang & Shangchun Sheng. (2019) Comparison of the diagnostic performance of fluorescence in situ hybridization (FISH), nuclear matrix protein 22 (NMP22), and their combination model in bladder carcinoma detection: a systematic review and meta-analysis. OncoTargets and Therapy 12, pages 349-358.
Read now
Read now
Elijah O. Kehinde, Fahd Al-Mulla, Kusum Kapila & Jehoram T. Anim. (2011) Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer. Scandinavian Journal of Urology and Nephrology 45:2, pages 113-121.
Read now
Read now
Vladimir Yutkin, Benjamin Nisman & Dov Pode. (2010) Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance?. Expert Review of Anticancer Therapy 10:6, pages 787-790.
Read now
Read now
Liang Cheng, Darrell D Davidson, Gregory T MacLennan, Sean R Williamson, Shaobo Zhang, Michael O Koch, Rodolfo Montironi & Antonio Lopez-Beltran. (2010) The origins of urothelial carcinoma. Expert Review of Anticancer Therapy 10:6, pages 865-880.
Read now
Read now
Articles from other publishers (36)
Lauren Lett, Michael George, Rachael Slater, Ben De Lacy Costello, Norman Ratcliffe, Marta García-Fiñana, Henry Lazarowicz & Chris Probert. (2022) Investigation of urinary volatile organic compounds as novel diagnostic and surveillance biomarkers of bladder cancer. British Journal of Cancer 127:2, pages 329-336.
Crossref
Crossref
Jing Xu, Danielle E Westfall & Jean R Lopategui. (2021) “Indeterminate” UroVysion Fluorescence In Situ Hybridization Results. American Journal of Clinical Pathology.
Crossref
Crossref
Feng Jin, Muhammad Shahid & Jayoung Kim. 2021. Translational Urinomics. Translational Urinomics
61
80
.
Fernando Agreda Castañeda, Carles Xavier Raventós Busquets & Juan Morote Robles. (2020) Assessing the Clinical Benefit of UBC Rapid in the Surveillance and Initial Diagnosis of Bladder Cancer. Clinical Genitourinary Cancer 18:3, pages 230-235.
Crossref
Crossref
Manuel Castanheira de Oliveira, Hugo R. Caires, Maria J. Oliveira, Avelino Fraga, M. Helena Vasconcelos & Ricardo Ribeiro. (2020) Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles. Cancers 12:6, pages 1400.
Crossref
Crossref
Haleem J. Issaq & Timothy D. Veenstra. 2020. Proteomic and Metabolomic Approaches to Biomarker Discovery. Proteomic and Metabolomic Approaches to Biomarker Discovery
1
16
.
F. Agreda Castañeda, C.X. Raventós Busquets & J. Morote Robles. (2019) Urinary markers in the surveillance of non-muscle invasive bladder cancer. A literature review. Actas Urológicas Españolas (English Edition) 43:8, pages 404-413.
Crossref
Crossref
F. Agreda Castañeda, C.X. Raventós Busquets & J. Morote Robles. (2019) Marcadores urinarios en la vigilancia del tumor vesical no músculo infiltrante. Revisión de la literatura. Actas Urológicas Españolas 43:8, pages 404-413.
Crossref
Crossref
Francesco Soria, Laura-Maria Krabbe, Tilman Todenhöfer, Jakub Dobruch, Anirban P. Mitra, Brant A. Inman, Kilian M. Gust, Yair Lotan & Shahrokh F. Shariat. (2018) Molecular markers in bladder cancer. World Journal of Urology 37:1, pages 31-40.
Crossref
Crossref
Francesco Soria, Michael J. Droller, Yair Lotan, Paolo Gontero, David D’Andrea, Kilian M. Gust, Morgan Rouprêt, Marek Babjuk, Joan Palou & Shahrokh F. Shariat. (2018) An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer. World Journal of Urology 36:12, pages 1981-1995.
Crossref
Crossref
Giorgio Santoni, Maria B. Morelli, Consuelo Amantini & Nicola Battelli. (2018) Urinary Markers in Bladder Cancer: An Update. Frontiers in Oncology 8.
Crossref
Crossref
Bert Dhondt, Jan Van Deun, Silke Vermaerke, Ario de Marco, Nicolaas Lumen, Olivier De Wever & An Hendrix. (2018) Urinary extracellular vesicle biomarkers in urological cancers: From discovery towards clinical implementation. The International Journal of Biochemistry & Cell Biology 99, pages 236-256.
Crossref
Crossref
Jie Lian, Shu-Hong Lin, Yuanqing Ye, David W. Chang, Maosheng Huang, Colin P. Dinney & Xifeng Wu. (2018) Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer. Oncotarget 9:19, pages 14895-14908.
Crossref
Crossref
Jamie J. D’Costa, James C. Goldsmith, Jayne S. Wilson, Richard T. Bryan & Douglas G. Ward. (2016) A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer. Bladder Cancer 2:3, pages 301-317.
Crossref
Crossref
HOUGUANG HE, CONGHUI HAN, LIN HAO & GUANGHUI ZANG. (2016) ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis. Oncology Letters 12:1, pages 83-88.
Crossref
Crossref
Ana Blanca, Maria J Requena, Jose Alvarez, Liang Cheng, Rodolfo Montironi, Maria R Raspollini, Carlos Reymundo & Antonio Lopez-Beltran. (2016) FGFR3 and Cyclin D3 as urine biomarkers of bladder cancer recurrence. Biomarkers in Medicine 10:3, pages 243-253.
Crossref
Crossref
Roger ChouJohn L. GoreDavid BuckleyRongwei FuKatie GustafsonJessica C. GriffinSara GrusingShelley Selph. (2015) Urinary Biomarkers for Diagnosis of Bladder Cancer. Annals of Internal Medicine 163:12, pages 922-931.
Crossref
Crossref
Faysal A. Yafi, Fadi Brimo, Jordan Steinberg, Armen G. Aprikian, Simon Tanguay & Wassim Kassouf. (2015) Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urologic Oncology: Seminars and Original Investigations 33:2, pages 66.e25-66.e31.
Crossref
Crossref
M Hammad AtherSyed M Nazim. (2015) New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer. Korean Journal of Urology 56:8, pages 553.
Crossref
Crossref
Bernd J. Schmitz-Dräger, Michael Droller, Vinata B. Lokeshwar, Yair Lotan, M''Liss A. Hudson, Bas W. van Rhijn, Michael J. Marberger, Yves Fradet, George P. Hemstreet, Per-Uno Malmstrom, Osamu Ogawa, Pierre I. Karakiewicz & Shahrokh F. Shariat. (2015) Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus. Urologia Internationalis 94:1, pages 1-24.
Crossref
Crossref
Bernd J. Schmitz-Dräger, Tilman Todenhöfer, Bas van Rhijn, Beate Pesch, Mĺiss A. Hudson, Ashish Chandra, Molly A. Ingersoll, Wassim Kassouf, Joan Palou, John Taylor, Antonia Vlahou, Thomas Behrens, Rossana Critelli, H. Barton Grossman, Marta Sanchez-Carbayo & Ashish Kamat. (2014) Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non–muscle invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations 32:7, pages 1061-1068.
Crossref
Crossref
Yu LiuElisabeth Drucker & Kurt Krapfenbauer. 2014. Omics in Clinical Practice. Omics in Clinical Practice
179
202
.
ZUNFU KE, YUANHUA LAI, XUDONG MA, SHUHUA LIL & WENHUA HUANG. (2014) Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization. Oncology Letters 7:2, pages 325-330.
Crossref
Crossref
Elisabeth Drucker & Kurt Krapfenbauer. (2013) Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA Journal 4:1.
Crossref
Crossref
M. Böhm, F. vom Dorp, M. Schostak & O.W. Hakenberg. (2013) Urinzytologie – Update 2013Urine cytology – update 2013. Der Urologe 52:9, pages 1207-1224.
Crossref
Crossref
M. Horstmann, T. Todenhöfer, J. Hennenlotter, S. Aufderklamm, J. Mischinger, U. Kuehs, G. Gakis, A. Stenzl & C. Schwentner. (2012) Influence of age on false positive rates of urine-based tumor markers. World Journal of Urology 31:4, pages 935-940.
Crossref
Crossref
Richard Morgan, Richard T. Bryan, Saqib Javed, Francesca Launchbury, Maurice P. Zeegers, K.K. Cheng, Nicholas D. James, D. Michael A. Wallace, Carolyn D. Hurst, Douglas G. Ward, Margaret A. Knowles & Hardev Pandha. (2013) Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker. European Journal of Cancer 49:9, pages 2214-2222.
Crossref
Crossref
Tilman Todenhöfer, Jörg Hennenlotter, Michael Esser, Sarah Mohrhardt, Veronika Tews, Stefan Aufderklamm, Georgios Gakis, Ursula Kuehs, Arnulf Stenzl & Christian Schwentner. (2012) Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. Cancer Cytopathology 121:5, pages 252-260.
Crossref
Crossref
Steve Goodison, Charles J. Rosser & Virginia Urquidi. (2013) Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests. Molecular Diagnosis & Therapy 17:2, pages 71-84.
Crossref
Crossref
Haleem J. Issaq & Timothy D. Veenstra. 2013. Proteomic and Metabolomic Approaches to Biomarker Discovery. Proteomic and Metabolomic Approaches to Biomarker Discovery
1
16
.
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
655
678
.
Marcus Horstmann. (2011) Currently Available Urine-Based Tumour Markers in the Detection of New and Recurrent Urothelial Bladder Cancer. Nephro-Urology Monthly 4:1, pages 345-349.
Crossref
Crossref
F. Saint, H. Quintens, M. Roupret, D. Amsellem-Ouazana, C. Mazerolles, H. Wallerand, S. Bernardini, L. Guy, M. Soulié & C. Pfister. (2011) Actualités urologiques concernant les tests diagnostiques utilisés pour les tumeurs de vessie : le NMP22. Progrès en Urologie 21:4, pages 245-249.
Crossref
Crossref
Liang Cheng, Shaobo Zhang, Gregory T. MacLennan, Sean R. Williamson, Antonio Lopez-Beltran & Rodolfo Montironi. (2011) Bladder cancer: translating molecular genetic insights into clinical practice. Human Pathology 42:4, pages 455-481.
Crossref
Crossref
Haleem J. Issaq, Timothy J. Waybright & Timothy D. Veenstra. (2011) Cancer biomarker discovery: Opportunities and pitfalls in analytical methods. ELECTROPHORESIS 32:9, pages 967-975.
Crossref
Crossref
Ian Proctor, Kai Stoeber & Gareth H Williams. (2010) Biomarkers in bladder cancer. Histopathology 57:1, pages 1-13.
Crossref
Crossref